Home/Filings/4/0001415889-24-011309
4//SEC Filing

Swanson Luke Roy 4

Accession 0001415889-24-011309

CIK 0001538379other

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 4:06 PM ET

Size

43.9 KB

Accession

0001415889-24-011309

Insider Transaction Report

Form 4
Period: 2024-04-22
Swanson Luke Roy
CHIEF TECHNOLOGY OFFICER
Transactions
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+39,32439,324 total
    Exercise: $12.75Exp: 2029-12-11Class A Common Stock (39,324 underlying)
  • Sale

    Class A Common Stock

    2024-04-22$88.00/sh140,538$12,367,344659,923 total
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+21,72821,728 total
    Exercise: $5.05Exp: 2028-01-25Class A Common Stock (21,728 underlying)
  • Other

    Common Stock

    2024-04-2245,0450 total(indirect: See footnote)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2250,0000 total
    Exercise: $8.30Exp: 2030-12-08Common Stock (50,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2225,0000 total
    Exercise: $19.25Exp: 2032-02-08Common Stock (25,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+25,00025,000 total
    Exercise: $19.25Exp: 2032-02-08Class A Common Stock (25,000 underlying)
  • Other

    Class A Common Stock

    2024-04-22+800,461800,461 total
  • Other

    Class A Common Stock

    2024-04-22+45,04545,045 total(indirect: See footnote)
  • Other

    Common Stock

    2024-04-22800,4610 total
  • Other

    Employee Stock Option (right to buy)

    2024-04-2221,7280 total
    Exercise: $5.05Exp: 2028-01-25Common Stock (21,728 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2235,0000 total
    Exercise: $5.35Exp: 2028-11-13Common Stock (35,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+35,00035,000 total
    Exercise: $5.35Exp: 2028-11-13Class A Common Stock (35,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2239,3240 total
    Exercise: $12.75Exp: 2029-12-11Common Stock (39,324 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+50,00050,000 total
    Exercise: $8.30Exp: 2030-12-08Class A Common Stock (50,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2271,6700 total
    Exercise: $22.20Exp: 2031-07-15Common Stock (71,670 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+71,67071,670 total
    Exercise: $22.20Exp: 2031-07-15Class A Common Stock (71,670 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-2240,0000 total
    Exercise: $10.40Exp: 2033-03-07Common Stock (40,000 underlying)
  • Other

    Employee Stock Option (right to buy)

    2024-04-22+40,00040,000 total
    Exercise: $10.40Exp: 2033-03-07Class A Common Stock (40,000 underlying)
Footnotes (9)
  • [F1]Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock (the "IPO").
  • [F2]The shares are held by Flat Tops Ventures, LLC, which is 1% owned by the Reporting Person and 99% owned by the Swanson 2021 Irrevocable Trust for the benefit of the Reporting Person's children.
  • [F3]Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
  • [F4]Pursuant to the IPO, on April 17, 2024, the Issuer, the selling stockholders named in the Underwriting Agreement (as defined below) and the underwriters of the IPO (the "Underwriters") entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, the Reporting Person sold 140,538 shares of Class A Common Stock of the Issuer to the Underwriters at a per share sale price of $88.00. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
  • [F5]All of the shares subject to the option are fully vested and exercisable as of the date hereof.
  • [F6]1/48th of the shares subject to the option vested on January 8, 2021 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date..
  • [F7]1/48th of the shares subject to the option vested on August 15, 2021 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.
  • [F8]1/36th of the shares subject to the option vested on February 3, 2022 and 1/36th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.
  • [F9]1/48th of the shares subject to the option vested on February 16, 2023 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Issuer

Ibotta, Inc.

CIK 0001538379

Entity typeother

Related Parties

1
  • filerCIK 0001873513

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 4:06 PM ET
Size
43.9 KB